Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Helwan University | OTHER |
| National Liver Institute, Egypt | OTHER |
Not provided
Not provided
Not provided
Not provided
In this study, investigators aim to explore the status of advanced endoscopy in different endoscopy units all over the world.
In this study, investigators aim to explore the status of advanced endoscopy (endoscopic retrograde cholangiopancreatography and endoscopic ultrasound on a global level) in different endoscopy units all over the world, to report the characteristics of patients presented to these units and their procedure details.
evaluate the validity of different GI societies recommendations applied in different GI endoscopy units on the prevention of SARS-CoV-2 nosocomial transmission and the overall impact of this recommendations on the service provided by each GI unit.
Target audience:
- Physicians performing advanced gastrointestinal endoscopies in different countries.
Objectives:
Primary objective:
1- To explore the status of advanced endoscopy (endoscopic retrograde cholangiopancreatography and endoscopic ultrasound on a global level) in different endoscopy units all over the world, to report the characteristics of patients presented to these units and their procedure details.
Secondary objectives:
Process:
A questionnaire containing advanced endoscopy procedure details in different countries will be distributed via emails. Responses will be collected in an online platform and data will be analyzed to reveal the effect of SARS-CoV-2 pandemic on different aspects of advanced endoscopy practice in the studied countries.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ERCP | Patients who will have endoscopic retrograde cholangiopancreatography |
| |
| EUS | Patients who will have endoscopic ultrasound |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Endoscopic management according to standard of care | Other | Endoscopic management according to standard of care by ERCP or EUS according to the indication in each case |
|
| Measure | Description | Time Frame |
|---|---|---|
| Age, gender, nationality | Investigators will report the baseline demographic data (age, gender, nationality) of all patients. | 3 months |
| Indication for procedure, status of SARS-CoV-2 infection | Investigators will report the baseline data clinical data (indication for procedure, status of SARS-CoV-2 infection) of all patients. | 3 months |
| Complete blood count and liver functions tests | Investigators will report the baseline laboratory data (complete blood count and liver functions tests) of all patients. | 3 months |
| procedure related complications | Investigators will report the procedure related complications. | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Effect of COVID-19 precautions on procedure time | Investigators will report wether the precautions lead to increase timing of the procedure | 3 months |
| Effect of COVID-19 precautions on staff number |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
All patients with digestive disorders referred for ERCP or EUS during the study period in the participating centers
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kings County Hospital Center, Brooklyn, NY, USA | Albertson | New York | 11507 | United States | ||
| Al-Azhar Univerisity |
Investigators may share data after first publication
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008105 | Liver Cirrhosis, Biliary |
| D018281 | Cholangiocarcinoma |
| D041781 | Jaundice, Obstructive |
| D010190 | Pancreatic Neoplasms |
| D000086382 | COVID-19 |
| D002761 | Cholangitis |
| ID | Term |
|---|---|
| D002780 | Cholestasis, Intrahepatic |
| D002779 | Cholestasis |
| D001649 | Bile Duct Diseases |
| D001660 | Biliary Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Investigators will report wether the precautions affected staff number (increased or decreased)
| 3 months |
| Cairo |
| 11651 |
| Egypt |
| University Medicine Greifswald | Greifswald | D-17475 | Germany |
| 2- Hospital Guillermo Kaelin De la Fuente - EsSalud | Lima | Peru |
| Singapore General Hospital | Singapore | 169856 | Singapore |
| D004066 |
| Digestive System Diseases |
| D008107 | Liver Diseases |
| D008103 | Liver Cirrhosis |
| D005355 | Fibrosis |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D000230 | Adenocarcinoma |
| D002277 | Carcinoma |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D007565 | Jaundice |
| D006932 | Hyperbilirubinemia |
| D012877 | Skin Manifestations |
| D012816 | Signs and Symptoms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D004701 | Endocrine Gland Neoplasms |
| D010182 | Pancreatic Diseases |
| D004700 | Endocrine System Diseases |
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D014777 | Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |